Interstitial Lung Diseases of Unknown Cause
- 26 January 1984
- journal article
- review article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 310 (4) , 235-244
- https://doi.org/10.1056/nejm198401263100406
Abstract
SarcoidosisSarcoidosis is a multisystem granulomatous disease of unknown cause characterized by enhanced cellular immune processes at sites of involvement.36,53,59, 152 Almost all organs can be affected by the disease, but the lower respiratory tract is the site most commonly associated with morbidity and mortality.152 At least 90 per cent of patients with sarcoidosis have pulmonary manifestations; 20 to 25 per cent of these patients have a permanent loss of lung function, and 5 to 10 per cent die from complications of the disease.153 , 154 Sarcoidosis is found throughout the world.152 153 154 155 In the industrialized nations, the prevalence varies by sex, geographic location, . . .Keywords
This publication has 34 references indexed in Scilit:
- Spontaneous Release of Interleukin-2 by Lung T Lymphocytes in Active Pulmonary SarcoidosisNew England Journal of Medicine, 1983
- Reactivity of Histiocytosis X Cells with Monoclonal Anti-T6 AntibodyNew England Journal of Medicine, 1982
- Chest radiological features of pulmonary histiocytosis X: a report based on 50 adult cases.Thorax, 1982
- Epidermal Langerhans cells are derived from cells originating in bone marrowNature, 1979
- Pulmonary SarcoidosisRespiration, 1979
- RACIAL DIFFERENCES IN SARCOIDOSISAnnals of the New York Academy of Sciences, 1976
- SARCOIDOSIS IN EUROPE: A COOPERATIVE STUDYAnnals of the New York Academy of Sciences, 1976
- Familial associations in sarcoidosis A report to the Research Committee of the British Thoracic and Tuberculosis AssociationTubercle, 1973
- Granulomatous Hypersensitivity (Part 1 of 2)Published by S. Karger AG ,1967
- Eosinophilic Xanthomatous Granuloma with Honeycomb LungsBMJ, 1949